Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 6/2011

01.07.2011 | Original Paper

Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late “catch-up” phenomenon after cypher® sirolimus-eluting stent implantation

verfasst von: Daniel Chamié, Alexandre Abizaid, J. Ribamar Costa Jr, Fausto Feres, J. Fábio Almiro da Silva, Luiz Alberto P. Mattos, Rodolfo Staico, Ricardo A. Costa, Andréa Abizaid, Luiz Fernando L. Tanajura, Amanda G. M. R. Sousa, J. Eduardo Sousa

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

Despite the expressive reduction in the intimal hyperplasia (IH) formation after DES implantation at the mid-term, late restenosis has been recently noticed. Our objective was to determine, by means of serial angiography (QCA) and intravascular ultrasound (IVUS) at two different time points, whether the occurrence of the “late catch-up” phenomenon occurs after sirolimus-eluting stent (SES) implantation. Thirty-eight non-complex patients treated with a single 18-mm SES who had systematic serial QCA and IVUS analyses at mean 8 and 20 months were enrolled. Primary endpoint is to evaluate the temporal course of IH formation after SES implantation, by comparing QCA in-stent late loss and IVUS percent IH obstruction between the invasive follow-ups. Mean cohort age was 59.3 years and 31.6% were diabetics. Baseline reference vessel diameter was 2.8 ± 0.4 mm and lesion length was 11.5 ± 3.5 mm. Left anterior descending artery was the most frequent target vessel (55.3%). Between 8 and 20 months, a non-significant increase in in-stent late loss from 0.10 ± 0.18 to 0.15 ± 0.30 mm (P = 0.38) was observed. By IVUS, a slight increase in the percent IH obstruction (1.03 ± 2.13 to 1.76 ± 1.87%, P = 0.12) was detected between the two evaluations. Interestingly, all the neoformed tissue accrued from 8 to 20 months accumulated in the distal portion of the stent. In the non-complex scenario, SES implantation was associated with a minimal, non-significant increase in the IH volume between 8 and 20 months.
Literatur
1.
Zurück zum Zitat Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R (2002) RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780PubMedCrossRef Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, Falotico R (2002) RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780PubMedCrossRef
2.
Zurück zum Zitat Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323PubMedCrossRef Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE (2003) SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315–1323PubMedCrossRef
3.
Zurück zum Zitat Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME (2004) TAXUS IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231PubMedCrossRef Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME (2004) TAXUS IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231PubMedCrossRef
4.
Zurück zum Zitat Serruys PW (2008) The SPIRIT II Study: a clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions: clinical, angiographic and IVUS 2 year results. Presented at: SCAI-ACCi2 Late Breaking Clinical Trial Sessions; 31 March 2008 Chicago, Ill Serruys PW (2008) The SPIRIT II Study: a clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions: clinical, angiographic and IVUS 2 year results. Presented at: SCAI-ACCi2 Late Breaking Clinical Trial Sessions; 31 March 2008 Chicago, Ill
5.
Zurück zum Zitat Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, Yeung AC, Llanos G, Dooley J, Falotico R (2004) Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 63:617–624PubMedCrossRef Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, Yeung AC, Llanos G, Dooley J, Falotico R (2004) Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 63:617–624PubMedCrossRef
6.
Zurück zum Zitat Farb A, Heller PF, Shroff S, Cheng L, Kolodgie FD, Carter AJ, Scott DS, Froehlich J, Virmani R (2001) Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104:473–479PubMedCrossRef Farb A, Heller PF, Shroff S, Cheng L, Kolodgie FD, Carter AJ, Scott DS, Froehlich J, Virmani R (2001) Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104:473–479PubMedCrossRef
7.
Zurück zum Zitat Liistro F, Stankovic G, Di Mario C, Takagi T, Chieffo A, Moshiri S, Montorfano M, Carlino M, Briguori C, Pagnotta P, Albiero R, Corvaja N, Colombo A (2002) First clinical experience with a paclitaxel derivative-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation 105:1883–1886PubMedCrossRef Liistro F, Stankovic G, Di Mario C, Takagi T, Chieffo A, Moshiri S, Montorfano M, Carlino M, Briguori C, Pagnotta P, Albiero R, Corvaja N, Colombo A (2002) First clinical experience with a paclitaxel derivative-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome. Circulation 105:1883–1886PubMedCrossRef
8.
Zurück zum Zitat Wessely R, Kastrati A, Schömig A (2005) Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. Ann Intern Med 143:392–394PubMed Wessely R, Kastrati A, Schömig A (2005) Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. Ann Intern Med 143:392–394PubMed
10.
Zurück zum Zitat Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Weissman NJ, Park SW, Park SJ (2006) Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation. Late catch-up phenomenon from ASPECT study. J Am Coll Cardiol 48:2432–2439PubMedCrossRef Park DW, Hong MK, Mintz GS, Lee CW, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Weissman NJ, Park SW, Park SJ (2006) Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation. Late catch-up phenomenon from ASPECT study. J Am Coll Cardiol 48:2432–2439PubMedCrossRef
11.
Zurück zum Zitat Cosgrave J, Qasim A, Latib A, Aranzulla TC, Colombo A (2007) Very late restenosis after paclitaxel-eluting stent implantation. Ann Intern Med 147:885–887PubMed Cosgrave J, Qasim A, Latib A, Aranzulla TC, Colombo A (2007) Very late restenosis after paclitaxel-eluting stent implantation. Ann Intern Med 147:885–887PubMed
12.
Zurück zum Zitat Cosgrave J, Corbett SJ, Melzi G, Babic R, Biondi-Zoccai GGL, Airoldi F, Chieffo A, Sangiorgi GM, Mantorfano M, Michev I, Carlino M, Colombo A (2007) Late restenosis following sirolimus-eluting stent implantation. Am J Cardiol 100:41–44PubMedCrossRef Cosgrave J, Corbett SJ, Melzi G, Babic R, Biondi-Zoccai GGL, Airoldi F, Chieffo A, Sangiorgi GM, Mantorfano M, Michev I, Carlino M, Colombo A (2007) Late restenosis following sirolimus-eluting stent implantation. Am J Cardiol 100:41–44PubMedCrossRef
13.
Zurück zum Zitat Cook S, Wenaweser P, Windecker S (2007) Very late restenosis of a sirolimus-eluting stent after left main coronary artery stenting. Can J Cardiol 23:64PubMedCrossRef Cook S, Wenaweser P, Windecker S (2007) Very late restenosis of a sirolimus-eluting stent after left main coronary artery stenting. Can J Cardiol 23:64PubMedCrossRef
14.
Zurück zum Zitat Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM (1990) Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 82:1193–1202PubMedCrossRef Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM (1990) Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 82:1193–1202PubMedCrossRef
15.
Zurück zum Zitat Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG (2001) American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37:1478–1492PubMedCrossRef Mintz GS, Nissen SE, Anderson WD, Bailey SR, Erbel R, Fitzgerald PJ, Pinto FJ, Rosenfield K, Siegel RJ, Tuzcu EM, Yock PG (2001) American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 37:1478–1492PubMedCrossRef
16.
Zurück zum Zitat Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115(18):2426–2434PubMedCrossRef Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S (2007) Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 115(18):2426–2434PubMedCrossRef
17.
Zurück zum Zitat Hong MK, Mintz GS, Lee GW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ (2006) Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113(3):414–419PubMedCrossRef Hong MK, Mintz GS, Lee GW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ (2006) Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 113(3):414–419PubMedCrossRef
18.
Zurück zum Zitat Kastrati A, Schömig A, Dietz R, Neumann FJ, Richardt G (1993) Time course of restenosis during the first year after emergency coronary stenting. Circulation 87:1498–1505PubMed Kastrati A, Schömig A, Dietz R, Neumann FJ, Richardt G (1993) Time course of restenosis during the first year after emergency coronary stenting. Circulation 87:1498–1505PubMed
19.
Zurück zum Zitat Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, Sato Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M (1996) Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 334:561–566PubMedCrossRef Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, Sato Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M (1996) Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 334:561–566PubMedCrossRef
20.
Zurück zum Zitat Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai k, Kaitani K, Inoue K, Nakagawa Y, Yokoi H, Iwabuchi M, Hamasaki N, Nosaka H, Nobuyoshi M (2002) Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 105:2986–2991PubMedCrossRef Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai k, Kaitani K, Inoue K, Nakagawa Y, Yokoi H, Iwabuchi M, Hamasaki N, Nosaka H, Nobuyoshi M (2002) Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation 105:2986–2991PubMedCrossRef
21.
Zurück zum Zitat Aoki J, Abizaid A, Serruys PW, Ong ATL, Boersma E, Sousa JE, Bruining N (2005) Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 46:1670–1676PubMedCrossRef Aoki J, Abizaid A, Serruys PW, Ong ATL, Boersma E, Sousa JE, Bruining N (2005) Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol 46:1670–1676PubMedCrossRef
22.
Zurück zum Zitat Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW, Sousa AGMR (2005) Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 111:2326–2329PubMedCrossRef Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW, Sousa AGMR (2005) Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation 111:2326–2329PubMedCrossRef
23.
Zurück zum Zitat Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys PW, TAXUS II Study Group (2005) Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112:3876–3883PubMedCrossRef Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys PW, TAXUS II Study Group (2005) Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation 112:3876–3883PubMedCrossRef
24.
Zurück zum Zitat Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER (2005) Strut position, blood flow, and drug deposition. Implication for single and overlapping drug-eluting stents. Circulation 111:2958–2965 Balakrishnan B, Tzafriri AR, Seifert P, Groothuis A, Rogers C, Edelman ER (2005) Strut position, blood flow, and drug deposition. Implication for single and overlapping drug-eluting stents. Circulation 111:2958–2965
25.
Zurück zum Zitat Mauri L, Orav EJ, Kuntz RE (2005) Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111:3435–3442PubMedCrossRef Mauri L, Orav EJ, Kuntz RE (2005) Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111:3435–3442PubMedCrossRef
26.
Zurück zum Zitat Sousa A, Costa JR Jr, Moreira AC, Cano M, Maldonado G, Costa RA, Pavanello R, Romano ER, Campos C, Haddad N, Abizaid A, Feres F, Mattos LA, Staico R, Sousa JE (2008) Drug-Eluting Stents in the Real World (DESIRE) Registry. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry. J Interv Cardiol 21:307–314PubMedCrossRef Sousa A, Costa JR Jr, Moreira AC, Cano M, Maldonado G, Costa RA, Pavanello R, Romano ER, Campos C, Haddad N, Abizaid A, Feres F, Mattos LA, Staico R, Sousa JE (2008) Drug-Eluting Stents in the Real World (DESIRE) Registry. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry. J Interv Cardiol 21:307–314PubMedCrossRef
27.
Zurück zum Zitat Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW (2009) Five-year follow-up after sirolimus-eluting stent implantation. Results of the SIRIUS (Sirolimus-eluting stent in de novo native coronary lesions) trial. J Am Coll Cardiol 53:1488–1497PubMedCrossRef Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW (2009) Five-year follow-up after sirolimus-eluting stent implantation. Results of the SIRIUS (Sirolimus-eluting stent in de novo native coronary lesions) trial. J Am Coll Cardiol 53:1488–1497PubMedCrossRef
Metadaten
Titel
Serial angiographic and intravascular ultrasound evaluation to interrogate the presence of late “catch-up” phenomenon after cypher® sirolimus-eluting stent implantation
verfasst von
Daniel Chamié
Alexandre Abizaid
J. Ribamar Costa Jr
Fausto Feres
J. Fábio Almiro da Silva
Luiz Alberto P. Mattos
Rodolfo Staico
Ricardo A. Costa
Andréa Abizaid
Luiz Fernando L. Tanajura
Amanda G. M. R. Sousa
J. Eduardo Sousa
Publikationsdatum
01.07.2011
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 6/2011
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-010-9723-z

Weitere Artikel der Ausgabe 6/2011

The International Journal of Cardiovascular Imaging 6/2011 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.